Pattern of DAP12 expression in leukocytes from both healthy and systemic lupus erythematosus patients

PLoS ONE

Volumn 4, Issue 7, 2009, Pages

  Schleinitz, Nicolas ^a   Chiche, Laurent ^a   Guia, Sophie ^b   Bouvier, Gaëlle ^c   Vernier, Julie ^c   Morice, Alexis ^b   Houssaint, Elisabeth ^b   Harlé, Jean Robert ^a   Kaplanski, Gilles ^a   Montero Julian, Félix A ^c   Vély, Frédéric ^d  

^a HÔPITAL DE LA CONCEPTION   (France)

^b INSERM   (France)

^c Immunotech   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN ANTIBODY; MONOCLONAL ANTIBODY; NATURAL KILLER CELL RECEPTOR; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TYROBP PROTEIN, HUMAN;

ADULT; ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; INNATE IMMUNITY; LEUKOCYTE; LYMPHOCYTE COUNT; MALE; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL COUNT; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; CASE CONTROL STUDY; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; CASE-CONTROL STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LEUKOCYTES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEMBRANE PROTEINS; RECEPTORS, IMMUNOLOGIC;

EID: 67650859937     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006264     Document Type: Article

References (31)

1. Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH (1998) Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391: 703-707.
2. Olcese L, Cambiaggi A, Semenzato G, Bottino C, Moretta A, et al. (1997) Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol 158: 5083-5086.
3. Tomasello E, Olcese L, Vely F, Geourgeon C, Blery M, et al. (1998) Gene structure, expression pattern, and biological activity of mouse killer cell activating receptor-associated protein (KARAP)/DAP-12. J Biol Chem 273: 34115-34119.
4. Lanier LL, Bakker AB (2000) The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function. Immunol Today 21: 611-614.
5. Tomasello E, Vivier E (2005) KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions. Eur J Immunol 35: 1670-1677.
6. Snyder MR, Lucas M, Vivier E, Weyand CM, Goronzy JJ (2003) Selective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP/DAP12 in CD4+ T cells. J Exp Med 197: 437-449.
7. van Bergen J, Thompson A, van der Slik A, Ottenhoff TH, Gussekloo J, et al. (2004) Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors. J Immunol 173: 6719-6726.
8. Kumagai H, Oki T, Tamitsu K, Feng SZ, Ono M, et al. (2003) Identification and characterization of a new pair of immunoglobulin-like receptors LMIR1 and 2 derived from murine bone marrow-derived mast cells. Biochem Biophys Res Commun 307: 719-729.
9. Yotsumoto K, Okoshi Y, Shibuya K, Yamazaki S, Tahara-Hanaoka S, et al. (2003) Paired activating and inhibitory immunoglobulin-like receptors, MAIR-I and MAIR-II, regulate mast cell and macrophage activation. J Exp Med 198: 223-233.
10. Snyder MR, Nakajima T, Leibson PJ, Weyand CM, Goronzy JJ (2004) Stimulatory killer Ig-like receptors modulate T cell activation through DAP12-dependent and DAP12-independent mechanisms. J Immunol 173: 3725-3731.
11. Hamerman JA, Jarjoura JR, Humphrey MB, Nakamura MC, Seaman WE, et al. (2006) Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Immunol 177: 2051-2055.
12. Hamerman JA, Tchao NK, Lowell CA, Lanier LL (2005) Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat Immunol 6: 579-586.
13. Sjolin H, Robbins SH, Bessou G, Hidmark A, Tomasello E, et al. (2006) DAP12 signaling regulates plasmacytoid dendritic cell homeostasis and down-modulates their function during viral infection. J Immunol 177: 2908-2916.
14. Paloneva J, Kestila M, Wu J, Salminen A, Bohling T, et al. (2000) Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat Genet 25: 357-361.
15. Cella M, Buonsanti C, Strader C, Kondo T, Salmaggi A, et al. (2003) Impaired differentiation of osteoclasts in TREM-2-deficient individuals. J Exp Med 198: 645-651.
16. Kaifu T, Nakahara J, Inui M, Mishima K, Momiyama T, et al. (2003) Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest 111: 323-332.
17. Nataf S, Anginot A, Vuaillat C, Malaval L, Fodil N, et al. (2005) Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages. Am J Pathol 166: 275-286.
18. Paloneva J, Mandelin J, Kiialainen A, Bohling T, Prudlo J, et al. (2003) DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features. J Exp Med 198: 669-675.
19. Erkeller-Yusel F, Hulstaart F, Hannet I, Isenberg D, Lydyard P (1993) Lymphocyte subsets in a large cohort of patients with systemic lupus erythematosus. Lupus 2: 227-231.
20. Green MR, Kennell AS, Larche MJ, Seifert MH, Isenberg DA, et al. (2005) Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients. Clin Exp Immunol 141: 165-173.
21. Toyabe S, Kaneko U, Uchiyama M (2004) Decreased DAP12 expression in natural killer lymphocytes from patients with systemic lupus erythematosus is associated with increased transcript mutations. J Autoimmun 23: 371-378.
22. Yabuhara A, Yang FC, Nakazawa T, Iwasaki Y, Mori T, et al. (1996) A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus. J Rheumatol 23: 171-177.
23. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, et al. (2002) Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci U S A 99: 4465-4470.
24. Schepis D, Gunnarsson I, Eloranta ML, Lampa J, Jacobson SH, et al. (2008) Increased proportion of CD56(bright) natural killer cells in active and inactive systemic lupus erythematosus. Immunology.
25. Pellett F, Siannis F, Vukin I, Lee P, Urowitz MB, et al. (2007) KIRs and autoimmune disease: studies in systemic lupus erythematosus and scleroderma. Tissue Antigens 69 Suppl 1: 106-108.
26. Izumi Y, Ida H, Huang M, Iwanaga N, Tanaka F, et al. (2006) Characterization of peripheral natural killer cells in primary Sjogren's syndrome: impaired NK cell activity and low NK cell number. J Lab Clin Med 147: 242-249.
27. Costello RT, Sivori S, Marcenaro E, Lafage-Pochitaloff M, Mozziconacci MJ, et al. (2002) Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood 99: 3661-3667.
28. Vely F, Gruel N, Moncuit J, Cochet O, Rouard H, et al. (1997) A new set of monoclonal antibodies against human Fc gamma RII (CD32) and Fc gamma RIII (CD16): characterization and use in various assays. Hybridoma 16: 519-528.
29. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35: 630-640.
30. Pascal V, Schleinitz N, Brunet C, Ravet S, Bonnet E, et al. (2004) Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions. Eur J Immunol 34: 2930-2940.
31. Anfossi N, Lucas M, Diefenbach A, Bühring H-J, Raulet D, et al. (2003) Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation of the RBL-2H3 leukemic mast cell line. Eur J Immunol 33: 3514-3522.